___

• 1. Xia, J., Hill, K.E., and Burke, R.F., Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defence indices in blood. J Nutr ,119, 1318-1326, 1989.
• 2. Magos, L., and Webb, M., The interaction of selenium with cadmium and mercury. CRC Crit Rev Toxicol ,8, 1-42, 1980.
• 3. Andersen, O., and Nielsen, J.B., Effects of simultaneous low-level dietary supplementation with inorganic and organic Se on blood and organ toxic levels of metals in mice. J Trace Elem Elect Health Dis, 7, 122, 1993.
• 4. Hui-Min, J., Guo'an, H., Xi, C., and Hongjun, Z., Effect of selenium on the change in cadmium-induced distribution of trace elements in pregnant rats. Trace Elem Elect, 14, 9-12, 1997.
• 5. Willett, W.C., Polk, B.F., Morris, J.S., Stanmpfer, M.J., Pressil, S., Rosner, B., Taylor, J.O., Schneider, K., and Hames, C.G., Prediagnostic serum selenium and risk of the cancer. Lancet, 2,130-134, 1983.
• 6. Helzlsouer, K.J., Comstock, G.W., and Morris, J.S., Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol and subsequent bladder cancer. Cancer Res, 49, 6144- 6148, 1989.
• 7. Overvad, K., Selenium and cancer in role of trace elements for health promotion and disease prevention, Sandstrom, B., and Walter , P. (eds) Kargel, Basel, 141-149, 1998.
• 8. Salonen, J.T., Salonen, R., Seppanen, K., Kantola, M., Paviainen, M., Alfthan, G., Maenpaa, P.H., Taskinen, E., and Rauramaa, R., Relationship of serum selenium and antioxidants to plasma lipoproteins, platelets aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis, 70, 155-160, 1988.
• 9. Korpela, H., Kumpulainen, J., Jussila, E., Kemila, S., Kaariainen, M., Kaariainen, T., and Sotaniemi, E.A., Effect of selenium supplementation after acute myocardial infarction. Res Commun Chem Pathol Pharmacol, 65, 249-252, 1989.
• 10. Korpela, H., Selenium in cardiovascular diseases-an update. J Trace Elem Electrolytes Health Dis,7,115, 1993
• 11. Hattunen, J.K., Selenium and cardiovascular diseases- an update. Biomed and Environ Sci, 10, 220-226, 1997.
• 12. Johansson,E., Selenium and its protection against the effects of mercury and silver. J Trace Elem Electrolytes Health Dis, 54, 273- 274, 1991.
• 13. Arthur, J.R., and Beckett, G.J., Selenium deficiency and tyroid homone metabolism. In Selenium In Bioloy And Medicine, Wendel, A. (Ed.), Berlin, Springer, 1989.
• 14. Arthur, J.R., Nicol, F., and Beckett, G.J., Hepatic iodothyronine 5' deiodinase:The role of selenium. Biochem J, 227, 537-540, 1990.
• 15. Clark, L.C., The epidemiology of selenium and cancer. Fed Proc, 44, 2584-2589, 1985.
• 16. Clark, L.C., and Combs, J.F. Jr., Selenium compounds and the prevention of cancer: Research needs and public health imlications. J Nut, 116, 170-176, 1986.
• 17. Combs, J.F.Jr., and Mercurio, S.D., Selenium and oxidative injury. In Nutritional diseases: Research directions in comperative pathology. Scarpelli, D., and Magaki, G. (Eds. ) New York, Liss, 1986.
• 18. Levander, O.A., Clinical consequences of low selenium intake and its relationship to vitamin E. Ann NY Acad Sci, 393,70-72, 1982.
• 19. Normura, A., Heilburn, L.K., Morris, J.S., and Stemmermann, G.N., Serum selenium and the risk of cancer by specific sites: Case-control analysis of prospective data. J Natl Cancer Inst, 79, 103-108, 1987.
• 20. Salonen, J.T., Selenium in ischaemic heart disease. Int J Epidemiol, 16, 323-328,1987. 21. WHO World Health Organization. Selenium and selenium compounds. JARC Monographs 9, 245-260, 1975.
• 22. Lou, H., Wu, R., and Fu, Y., Relation between selenium and cancer of uterine cervix. Chinese J Oncol 17, 112-114, 1995.
• 23. Fleet, J.C., Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium. Nutr Rev, 55,277-279, 1997.
• 24. Cowgill, U.M., The distribution of selenium and mortality owing to acquired immune deficiency syndrom in the continental United States. Biol Trace Elem Res, 56, 43-61, 1997.
• 25. Ward, K.P., Arthur, J.R., Russell, G., and Aggett, P.J., Blood selenium content and glutathione peroxidase activity in children with cystic fisrosis, coliac disease, asthma, and epilepsy. Eur J Pediatr, 142, 21-24, 1984.
• 26. Hinks, L.J., Inwards, K.D., Lloyd, B., and Clayton, B., Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol, 41, 198- 201, 1988.
• 27. Robberecht, H., Deelstra, H., and Van Grieken, R., Determination of selenium in blood components by X-ray emission spectrometry: Procedures, concentration levels and health implications. Biol Trace Elem Res, 25, 149-185, 1990.
• 28. Mtsuda, A., Kimura, M., and Itokawa, Y., Selenium level and glutathione peroxidase activity in plasma , eryhrocytes and platelets of healthy Japanese volunteers. J Nutr Sci Vitaminol, 43, 497-504, 1997.
• 29. Van Cauwenbergh, R., Robberdeccht, H., Deelstra, H., picramenos, D., and Kostakpoulos, A., Selenium concentrations in healthy Greek adults. J Trace Elem electrolytes Health Dis, 8, 99-109, 1994.
• 30. Scieszka, M., Danch, A., Machalski, M., and Drozda, M., Plasma selenium concentration in patients with stomach and colon cancer in the upper Silesia. Neoplasma, 44, 395-397, 1997.
• 31. Hughes, K., and Ong, C., Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singhapore. J. Epidemiol and Community Health, 52, 181-185, 1998.
• 32. Makropoulos, W., Heintz, B., and Stefanidis, I., Selenium deficiency and thyroid function in acute renal failure. Renal Failure, 19, 129-136, 1997.
• 33. Chen, X.S., Yang, G.Q., Chen, X.C., Wen, Z.M., and Ge, K.Y., Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res, 2, 97-107, 1980.
• 34. Keshan Disease Research Group Of The Chinese Academy Of Medical Sciences, Beijing, Epidemiological studies on the etiologic relationship of selenium and Keshan disease. Chin Med J, 92, 477-482, 1979.
• 35. Salonen, J.T., Alfthan, G., Huttunen, J.K., Pikkarainen, J., and Puska, P., Association between cardiovascular death and myocardial infarction and serum selenium in a matchedpair longitutional study. Lancet, 2, 175-191, 1982.
• 36. Salonen, J.T., Salonen, R., Pentilla, J., Jauhiainen, M., Kantola, M., Lappetelainen, R., Maenpaa, P.H., Alfthan, G., and Puska, P., Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol, 56, 226-231, 1985.
• 37. Miettinen, T.A., Alfthan, G., Huttunen, J.K., Pikkarainen, J., Naukkarinen, V., Mattila, S., and Kumlint, t., Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br Med J, 287, 517- 519, 1983.
• 38. Virttamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J.K., and Karvonen, M., Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 122, 276-282, 1985.
• 39. Kok, F.J., De Bruijn, A.M., Vermeeren, R., Hofman, A., vanlaar, A., De Bruin, M., Hermus, R.J., and Valkenburg, H.a., Serum selenium, vitamin antioxdants and the cardivascular mortality: A 9 year follow-up study in the Netherlands. Am J Clin Nutr, 45, 462-468, 1987.
• 40. Ringstad, J., And, D.S., Thelle, D.S., Risk of myocardial infarction in relation to serum concentrations of selenium. Acta Pharmacol Toxicol, 59, 336-339, 1986.
• 41. Weltz, B., Wolynetz, M., Verlinden, M., Interlaboratory trial on the determination of selenium in lyophilizied human serum, blood, and urine using hydride generation atomic absorbtion spectrometry. Pure and Applied Chem, 59(71), 927-936, 1987.
• 42. Arıcı, H., İstatistik, Meteksan Yayınları, s 230, 1991.
• 43. Oster, O., Prellwitz, W., Kaspen, W., Meinertz, T., Congestive cardiomyopathy and the selenium content of serum. Clin Chim Acta, 128, 125-132, 1983.
• 44. Al-Saleh, I., Selenium status in Saudi Arabia. J Trace Elem in Medicine and Biology, 14(3), 154-160,2000.
• 45. Al-Saleh, I., Billedo,G., El-Doush,I., El-Din Mohammed, G., and Yosef,G., Selenium and vitamins status in Saudi children. Clinica Chimica Acta, 368(1-2), 99-109, 2006.